{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T06:15:22Z","timestamp":1783145722138,"version":"3.54.6"},"reference-count":107,"publisher":"Japanese Society for Hygiene","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Environ. Health Prev. Med.","Environ Health Prev Med"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1265\/ehpm.25-00395","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:10:23Z","timestamp":1783030223000},"page":"44-44","source":"Crossref","is-referenced-by-count":0,"title":["Occurrence of antibacterials, antivirals, and anti-inflammatory pharmaceuticals for COVID-19 treatment as emerging contaminants in the Chinese freshwater environment before, during and after the pandemic: the need for dynamic eco-pharmacovigilance"],"prefix":"10.1265","volume":"31","author":[{"given":"Sijia","family":"Ma","sequence":"first","affiliation":[{"name":"Institute of Pharmaceutical Innovation, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, School of Medicine, Wuhan University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Innovation, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, School of Medicine, Wuhan University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Innovation, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, School of Medicine, Wuhan University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"335","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Pa\u00edga P, Correia-S\u00e1 L, Correia M, Figueiredo S, Vieira J, Jorge S, Silva JG, Delerue-Matos C. Temporal Analysis of Pharmaceuticals as Emerging Contaminants in Surface Water and Wastewater Samples: A Case Study. J Xenobiot. 2024;14(3):873\u201392.","DOI":"10.3390\/jox14030048"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Gao J, Zhao J, Chen X, Wang J. A review on in silico prediction of the environmental risks posed by pharmaceutical emerging contaminants. Environ Monit Assess. 2023;195(12):1535.","DOI":"10.1007\/s10661-023-12159-9"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Oldenkamp R, Hamers T, Wilkinson J, Slootweg J, Posthuma L. Regulatory Risk Assessment of Pharmaceuticals in the Environment: Current Practice and Future Priorities. Environ Toxicol Chem. 2024;43(3):611\u201322.","DOI":"10.1002\/etc.5535"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Wang J, Li S, Zhu Y, Guo J, Liu J, He B. Targeted eco-pharmacovigilance as an optimized management strategy for adverse effects of pharmaceuticals in the environment. Environ Toxicol Pharmacol. 2021;82:103565.","DOI":"10.1016\/j.etap.2020.103565"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Nadeem S, Aamdani SS, Ayub B, Rizvi NA, Arslan FS, Martins RS, Khan M, Mahmood SF. Development of Evidence-Based COVID-19 Management Guidelines for Local Context: The Methodological Challenges. Glob Health Epidemiol Genom. 2022;2022:4240378.","DOI":"10.1155\/2022\/4240378"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Bartoletti M, Azap O, Barac A, Bussini L, Ergonul O, Krause R, Pa\u00f1o-Pardo JR, Power NR, Sibani M, Szabo BG, Tsiodras S, Verweij PE, Zollner-Schwetz I, Rodr\u00edguez-Ba\u00f1o J. ESCMID COVID-19 living guidelines: drug treatment and clinical management. Clin Microbiol Infect. 2022;28(2):222\u201338.","DOI":"10.1016\/j.cmi.2021.11.007"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. WHO Solidarity Trial Consortium. Repurposed Antiviral Drugs for Covid-19\u2014Interim WHO Solidarity Trial Results. N Engl J Med. 2021;384(6):497\u2013511.","DOI":"10.1056\/NEJMoa2023184"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Malik SS, Mundra S. Increasing Consumption of Antibiotics during the COVID-19 Pandemic: Implications for Patient Health and Emerging Anti-Microbial Resistance. Antibiotics. 2022;12(1):45.","DOI":"10.3390\/antibiotics12010045"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Shakeri A, Konstantelos N, Chu C, Antoniou T, Feld J, Suda KJ, Tadrous M. Global Utilization Trends of Direct Acting Antivirals (DAAs) during the COVID-19 Pandemic: A Time Series Analysis. Viruses. 2021;13(7):1314.","DOI":"10.3390\/v13071314"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Al-Azzam S, Mhaidat NM, Banat HA, Alfaour M, Ahmad DS, Muller A, Al-Nuseirat A, Lattyak EA, Conway BR, Aldeyab MA. An Assessment of the Impact of Coronavirus Disease (COVID-19) Pandemic on National Antimicrobial Consumption in Jordan. Antibiotics. 2021;10(6):690.","DOI":"10.3390\/antibiotics10060690"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Wojcieszy\u0144ska D, Guzik H, Guzik U. Non-steroidal anti-inflammatory drugs in the era of the Covid-19 pandemic in the context of the human and the environment. Sci Total Environ. 2022;834:155317.","DOI":"10.1016\/j.scitotenv.2022.155317"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Yousefi B, Valizadeh S, Ghaffari H, Vahedi A, Karbalaei M, Eslami M. A global treatments for coronaviruses including COVID-19. J Cell Physiol. 2020;235(12):9133\u201342.","DOI":"10.1002\/jcp.29785"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Choudhury A, Ojha PK, Ray S. Hazards of antiviral contamination in water: Dissemination, fate, risk and their impact on fish. J Hazard Mater. 2024;476:135087.","DOI":"10.1016\/j.jhazmat.2024.135087"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sulis G, Pai M, Gandra S. Comment on: Global consumption of antimicrobials: impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 coronavirus pandemic (COVID-19). J Antimicrob Chemother. 2022;77(10):2891\u20132.","DOI":"10.1093\/jac\/dkac180"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Amponsah SK, Tagoe B, Adams I, Bugyei KA. Efficacy and safety profile of corticosteroids and non-steroidal anti-inflammatory drugs in COVID-19 management: A narrative review. Front Pharmacol. 2022;13:1063246.","DOI":"10.3389\/fphar.2022.1063246"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Zhao H, Huang S, Huang S, Liu F, Shao W, Mei K, Ma J, Jiang Y, Wan J, Zhu W, Yu P, Liu X. Prevalence of NSAID use among people with COVID-19 and the association with COVID-19-related outcomes: Systematic review and meta-analysis. Br J Clin Pharmacol. 2022;88(12):5113\u201327.","DOI":"10.1111\/bcp.15512"},{"key":"17","unstructured":"17. World Health Organization. Corticosteroids for COVID-19: Living Guidance, 2 September 2020; World Health Organization: Geneva, Switzerland, 2020; Available online: https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Corticosteroids-2020.1 (accessed on 6 October 2025)."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Akter F, Araf Y, Hosen MJ. Corticosteroids for COVID-19: worth it or not? Mol Biol Rep. 2022;49(1):567\u201376.","DOI":"10.1007\/s11033-021-06793-0"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kumar M, Mazumder P, Silori R, Manna S, Panday DP, Das N, Sethy SK, Kuroda K, Mahapatra DM, Mahlknecht J, Tyagi VK, Singh R, Zang J, Barcel\u00f3 D. Prevalence of pharmaceuticals and personal care products, microplastics and co-infecting microbes in the post-COVID-19 era and its implications on antimicrobial resistance and potential endocrine disruptive effects. Sci Total Environ. 2023;904:166419.","DOI":"10.1016\/j.scitotenv.2023.166419"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Morales-Paredes CA, Rodr\u00edguez-D\u00edaz JM, Boluda-Botella N. Pharmaceutical compounds used in the COVID-19 pandemic: A review of their presence in water and treatment techniques for their elimination. Sci Total Environ. 2022;814:152691.","DOI":"10.1016\/j.scitotenv.2021.152691"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Gwenzi W, Selvasembian R, Offiong NO, Mahmoud AED, Sanganyado E, Mal J. COVID-19 drugs in aquatic systems: a review. Environ Chem Lett. 2022;20(2):1275\u201394.","DOI":"10.1007\/s10311-021-01356-y"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kahssay SW, Hammeso WW, Getachew D, Woldeselassie BD. Prevalence and Determinants of Household Medication Storage During the COVID-19 Outbreak in Southwest Ethiopia. Drug Healthc Patient Saf. 2023;15:1\u201311.","DOI":"10.2147\/DHPS.S392564"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Khan K, Kar S, Roy K. Are we ready to combat the ecotoxicity of COVID-19 pharmaceuticals? An in silico aquatic risk assessment. Aquat Toxicol. 2023;256:106416.","DOI":"10.1016\/j.aquatox.2023.106416"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Guo Z, Kodikara D, Albi LS, Hatano Y, Chen G, Yoshimura C, Wang J. Photodegradation of organic micropollutants in aquatic environment: Importance, factors and processes. Water Res. 2023;231:118236.","DOI":"10.1016\/j.watres.2022.118236"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Richardson ML, Bowron JM. The fate of pharmaceutical chemicals in the aquatic environment. J Pharm Pharmacol. 1985;37(1):1\u201312.","DOI":"10.1111\/j.2042-7158.1985.tb04922.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. L\u00f6ffler D, R\u00f6mbke J, Meller M, Ternes TA. Environmental fate of pharmaceuticals in water\/sediment systems. Environ Sci Technol. 2005;39(14):5209\u201318.","DOI":"10.1021\/es0484146"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Guo Z, Wang T, Chen G, Wan J, Fujii M, Yoshimura C. Apparent quantum yield for photo-production of singlet oxygen in reservoirs and its relation to the water matrix. Water Res. 2023;244:120456.","DOI":"10.1016\/j.watres.2023.120456"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Guo Z, Wang T, Ichiyanagi H, Ateia M, Chen G, Wang J, Fujii M, En K, Li T, Sohrin R, Yoshimura C. Photo-production of excited triplet-state of dissolved organic matters in inland freshwater and coastal seawater. Water Res. 2024;253:121260.","DOI":"10.1016\/j.watres.2024.121260"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Nannou C, Ofrydopoulou A, Evgenidou E, Heath D, Heath E, Lambropoulou D. Antiviral drugs in aquatic environment and wastewater treatment plants: A review on occurrence, fate, removal and ecotoxicity. Sci Total Environ. 2020;699:134322.","DOI":"10.1016\/j.scitotenv.2019.134322"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Wang R, Luo J, Li C, Chen J, Zhu N. Antiviral drugs in wastewater are on the rise as emerging contaminants: A comprehensive review of spatiotemporal characteristics, removal technologies and environmental risks. J Hazard Mater. 2023;457:131694.","DOI":"10.1016\/j.jhazmat.2023.131694"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Zhou J, Yun X, Wang J, Li Q, Wang Y. A review on the ecotoxicological effect of sulphonamides on aquatic organisms. Toxicol Rep. 2022;9:534\u201340.","DOI":"10.1016\/j.toxrep.2022.03.034"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Shen M, Hu Y, Zhao K, Li C, Liu B, Li M, Lyu C, Sun L, Zhong S. Occurrence, Bioaccumulation, Metabolism and Ecotoxicity of Fluoroquinolones in the Aquatic Environment: A Review. Toxics. 2023;11(12):966.","DOI":"10.3390\/toxics11120966"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Yang Q, Gao Y, Ke J, Show PL, Ge Y, Liu Y, Guo R, Chen J. Antibiotics: An overview on the environmental occurrence, toxicity, degradation, and removal methods. Bioengineered. 2021;12(1):7376\u2013416.","DOI":"10.1080\/21655979.2021.1974657"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Du J, Huang W, Pan Y, Xu S, Li H, Jin M, Liu Q. Ecotoxicological Effects of Microplastics Combined With Antibiotics in the Aquatic Environment: Recent Developments and Prospects. Environ Toxicol Chem. 2024;43(9):1950\u201361.","DOI":"10.1002\/etc.5950"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. He BS, Wang J, Liu J, Hu XM. Eco-pharmacovigilance of non-steroidal anti-inflammatory drugs: Necessity and opportunities. Chemosphere. 2017;181:178\u201389.","DOI":"10.1016\/j.chemosphere.2017.04.084"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Parolini M. Toxicity of the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) acetylsalicylic acid, paracetamol, diclofenac, ibuprofen and naproxen towards freshwater invertebrates: A review. Sci Total Environ. 2020;740:140043.","DOI":"10.1016\/j.scitotenv.2020.140043"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Ferreira BL, Ferreira DP, Borges SF, Ferreira AM, Holanda FH, Ucella-Filho JGM, Cruz RAS, Birolli WG, Luque R, Ferreira IM. Diclofenac, ibuprofen, and paracetamol biodegradation: overconsumed non-steroidal anti-inflammatories drugs at COVID-19 pandemic. Front Microbiol. 2023;14:1207664.","DOI":"10.3389\/fmicb.2023.1207664"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Gong J, Lin C, Xiong X, Chen D, Chen Y, Zhou Y, Wu C, Du Y. Occurrence, distribution, and potential risks of environmental corticosteroids in surface waters from the Pearl River Delta, South China. Environ Pollut. 2019;251:102\u20139.","DOI":"10.1016\/j.envpol.2019.04.110"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Bal N, Kumar A, Du J, Nugegoda D. Multigenerational effects of two glucocorticoids (prednisolone and dexamethasone) on life-history parameters of crustacean Ceriodaphnia dubia (Cladocera). Environ Pollut. 2017;225:569\u201378.","DOI":"10.1016\/j.envpol.2017.03.024"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Guti\u00e9rrez-Noya VM, G\u00f3mez-Oliv\u00e1n LM, Casas-Hinojosa I, Garc\u00eda-Medina S, Rosales-P\u00e9rez KE, Orozco-Hern\u00e1ndez JM, Elizalde-Vel\u00e1zquez GA, Galar-Mart\u00ednez M, Dubl\u00e1n-Garc\u00eda O, Islas-Flores H. Short-term exposure to dexamethasone at environmentally relevant concentrations impairs embryonic development in Cyprinus carpio: Bioconcentration and alteration of oxidative stress-related gene expression patterns. Sci Total Environ. 2023;898:165528.","DOI":"10.1016\/j.scitotenv.2023.165528"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Kugathas S, Sumpter JP. Synthetic glucocorticoids in the environment: first results on their potential impacts on fish. Environ Sci Technol. 2011;45(6):2377\u201383.","DOI":"10.1021\/es104105e"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Musee N, Kebaabetswe LP, Tichapondwa S, Tubatsi G, Mahaye N, Leareng SK, Nomngongo PN. Occurrence, Fate, Effects, and Risks of Dexamethasone: Ecological Implications Post-COVID-19. Int J Environ Res Public Health. 2021;18(21):11291.","DOI":"10.3390\/ijerph182111291"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Jim\u00e9nez-Bambague EM, Madera-Parra CA, Machuca-Martinez F. The occurrence of emerging compounds in real urban wastewater before and after the COVID-19 pandemic in Cali, Colombia. Curr Opin Environ Sci Health. 2023;33:100457.","DOI":"10.1016\/j.coesh.2023.100457"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. O\u2019Flynn D, Lawler J, Yusuf A, Parle-McDermott A, Harold D, Mc Cloughlin T, Holland L, Regan F, White B. A review of pharmaceutical occurrence and pathways in the aquatic environment in the context of a changing climate and the COVID-19 pandemic. Anal Methods. 2021;13(5):575\u201394.","DOI":"10.1039\/D0AY02098B"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Pic\u00f3 Y, Barcel\u00f3 D. Microplastics and other emerging contaminants in the environment after COVID-19 pandemic: The need of global reconnaissance studies. Curr Opin Environ Sci Health. 2023;33:100468.","DOI":"10.1016\/j.coesh.2023.100468"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Xia X, Mu H, Li Y, Hou Y, Li J, Zhao Z, Zhao Q, You S, Wei L. Which emerging micropollutants deserve more attention in wastewater in the post-COVID-19 pandemic period? Based on distribution, risk, and exposure analysis. Sci Total Environ. 2024;951:175511.","DOI":"10.1016\/j.scitotenv.2024.175511"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Jose J, Sandra Pinto J, Kotian B, Mathew Thomas A, Narayana Charyulu R. Comparison of the regulatory outline of ecopharmacovigilance of pharmaceuticals in Europe, USA, Japan and Australia. Sci Total Environ. 2020;709:134815.","DOI":"10.1016\/j.scitotenv.2019.134815"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Li S, He B, Wang J, Liu J, Hu X. Risks of caffeine residues in the environment: Necessity for a targeted ecopharmacovigilance program. Chemosphere. 2020;243:125343.","DOI":"10.1016\/j.chemosphere.2019.125343"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Holm G, Snape JR, Murray-Smith R, Talbot J, Taylor D, S\u00f6rme P. Implementing ecopharmacovigilance in practice: challenges and potential opportunities. Drug Saf. 2013;36(7):533\u201346.","DOI":"10.1007\/s40264-013-0049-3"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Medeiros AS, Milo\u0161evi\u0107 D. Progress in understanding the vulnerability of freshwater ecosystems. Sci Prog. 2023;106(2):368504231173840.","DOI":"10.1177\/00368504231173840"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Jin Z, Liu JY, Feng R, Ji L, Jin ZL, Li HB. Drug treatment of coronavirus disease 2019 (COVID-19) in China. Eur J Pharmacol. 2020;883:173326.","DOI":"10.1016\/j.ejphar.2020.173326"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Dai H, Wang C, Yu W, Han J. Tracing COVID-19 drugs in the environment: Are we focusing on the right environmental compartment? Environ Pollut. 2023;339:122732.","DOI":"10.1016\/j.envpol.2023.122732"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Sunder S, Bhandari K, Sounkaria S, Vyas M, Singh BP, Chandra P. Antibiotics and nano-antibiotics in treatment of lung infection: In management of COVID-19. Microb Pathog. 2023;184:106356.","DOI":"10.1016\/j.micpath.2023.106356"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Langford BJ, So M, Raybardhan S, Leung V, Soucy JR, Westwood D, Daneman N, MacFadden DR. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect. 2021;27(4):520\u201331.","DOI":"10.1016\/j.cmi.2020.12.018"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Popp M, Stegemann M, Riemer M, Metzendorf MI, Romero CS, Mikolajewska A, Kranke P, Meybohm P, Skoetz N, Weibel S. Antibiotics for the treatment of COVID-19. Emergencias. 2023;35(5):378\u201380.","DOI":"10.55633\/s3me\/E028.2023"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Yang Y, Geng X, Liu X, Wen X, Wu R, Cui D, Mao Z. Antibiotic Use in China\u2019s Public Healthcare Institutions During the COVID-19 Pandemic: An Analysis of Nationwide Procurement Data, 2018\u20132020. Front Pharmacol. 2022;13:813213.","DOI":"10.3389\/fphar.2022.813213"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Liu S, Hu K, Xie Z, Wang Y. Spatialtemporal change of river thermal environment and anthropogenic impact in China. Sci Total Environ. 2024;929:172697.","DOI":"10.1016\/j.scitotenv.2024.172697"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Yao XX, Zeng CF, Duan XJ, Wang YZ. Effects of land use patterns on seasonal water quality in Chinese basins at multiple temporal and spatial scales. Ecol Indic. 2024;166:112423.","DOI":"10.1016\/j.ecolind.2024.112423"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Fang L, Wang L, Chen W, Sun J, Wang L. Identifying the impacts of natural and human factors on ecosystem service in the yangtze and yellow river basins. J Clean Prod. 2021;314:127995.","DOI":"10.1016\/j.jclepro.2021.127995"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Wu C, Huang X, Witter JD, Spongberg AL, Wang K, Wang D, Liu J. Occurrence of pharmaceuticals and personal care products and associated environmental risks in the central and lower Yangtze river, China. Ecotoxicol Environ Saf. 2014;106:19\u201326.","DOI":"10.1016\/j.ecoenv.2014.04.029"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Yang Y, Chen Z, Zhang J, Wu S, Yang L, Chen L, Shao Y. The challenge of micropollutants in surface water of the Yangtze River. Sci Total Environ. 2021;780:146537.","DOI":"10.1016\/j.scitotenv.2021.146537"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Wang G, Zhou S, Han X, Zhang L, Ding S, Li Y, Zhang D, Zarin K. Occurrence, distribution, and source track of antibiotics and antibiotic resistance genes in the main rivers of Chongqing city, Southwest China. J Hazard Mater. 2020;389:122110.","DOI":"10.1016\/j.jhazmat.2020.122110"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Lin H, Chen L, Li H, Luo Z, Lu J, Yang Z. Pharmaceutically active compounds in the Xiangjiang River, China: Distribution pattern, source apportionment, and risk assessment. Sci Total Environ. 2018;636:975\u201384.","DOI":"10.1016\/j.scitotenv.2018.04.267"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Wang N, Wang N, Qi D, Kang G, Wang W, Zhang C, Zhang Z, Zhang Y, Zhang H, Zhang S, Xu J. Comprehensive overview of antibiotic distribution, risk and priority: A study of large-scale drinking water sources from the lower Yangtze River. J Environ Manage. 2023;344:118705.","DOI":"10.1016\/j.jenvman.2023.118705"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Jiang L, Zhai W, Wang J, Li G, Zhou Z, Li B, Zhuo H. Antibiotics and antibiotic resistance genes in the water sources of the Wuhan stretch of the Yangtze River: Occurrence, distribution, and ecological risks. Environ Res. 2023;239(Pt 1):117295.","DOI":"10.1016\/j.envres.2023.117295"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Zhou H, Ying T, Wang X, Liu J. Occurrence and preliminarily environmental risk assessment of selected pharmaceuticals in the urban rivers, China. Sci Rep. 2016;6:34928.","DOI":"10.1038\/srep34928"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Chen M, Jin X, Liu Y, Guo L, Ma Y, Guo C, Wang F, Xu J. Human activities induce potential aquatic threats of micropollutants in Danjiangkou Reservoir, the largest artificial freshwater lake in Asia. Sci Total Environ. 2022;850:157843.","DOI":"10.1016\/j.scitotenv.2022.157843"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Luo Y, Jin X, Zhao J, Xie H, Guo X, Huang D, Giesy JP, Xu J. Ecological implications and drivers of emerging contaminants in Dongting Lake of Yangtze River Basin, China: A multi-substance risk analysis. J Hazard Mater. 2024;472:134519.","DOI":"10.1016\/j.jhazmat.2024.134519"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Chen X, Lei L, Liu S, Han J, Li R, Men J, Li L, Wei L, Sheng Y, Yang L, Zhou B, Zhu L. Occurrence and risk assessment of pharmaceuticals and personal care products (PPCPs) against COVID-19 in lakes and WWTP-river-estuary system in Wuhan, China. Sci Total Environ. 2021;792:148352.","DOI":"10.1016\/j.scitotenv.2021.148352"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Gao FZ, He LY, Hu LX, Chen J, Yang YY, He LX, Bai H, Liu YS, Zhao JL, Ying GG. The variations of antibiotics and antibiotic resistance genes in two subtropical large river basins of south China: Anthropogenic impacts and environmental risks. Environ Pollut. 2022;312:119978.","DOI":"10.1016\/j.envpol.2022.119978"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Peng X, Yu Y, Tang C, Tan J, Huang Q, Wang Z. Occurrence of steroid estrogens, endocrine-disrupting phenols, and acid pharmaceutical residues in urban riverine water of the Pearl River Delta, South China. Sci Total Environ. 2008;397:158\u201366.","DOI":"10.1016\/j.scitotenv.2008.02.059"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. Long Y, Song L, Shu Y, Li B, Peijnenburg W, Zheng C. Evaluating the spatial and temporal distribution of emerging contaminants in the Pearl River Basin for regulating purposes. Ecotoxicol Environ Saf. 2023;257:114918.","DOI":"10.1016\/j.ecoenv.2023.114918"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. Wang C, Zhao Y, Liu S, Xiao Q, Liang W, Song Y. Contamination, distribution, and risk assessment of antibiotics in the urban surface water of the Pearl River in Guangzhou, South China. Environ Monit Assess. 2021;193(2):98.","DOI":"10.1007\/s10661-021-08887-5"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74. Zhang Y, Li J, Wu T, Ma K, Cheng Z, Yi Q, Dai Y, Wang B, Chen Y, Wang B, Hu X, Yang A, Yang Q, Zhong X. Characteristics of antibiotic resistance genes and microbial community distribution in Wanfeng Lake, upper Pearl River, China. Environ Sci Pollut Res Int. 2023;30:83214\u201330.","DOI":"10.1007\/s11356-023-28158-9"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75. Zhang H, Ouyang W, Lin C, Wang L, Guo Z, Pei J, Zhang S, He M, Liu X. Anthropogenic activities drive the distribution and ecological risk of antibiotics in a highly urbanized river basin. Sci Total Environ. 2024;938:173596.","DOI":"10.1016\/j.scitotenv.2024.173596"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76. Yu X, Yu F, Li Z, Zhan J. Occurrence, distribution, and ecological risk assessment of pharmaceuticals and personal care products in the surface water of the middle and lower reaches of the Yellow River (Henan section). J Hazard Mater. 2023;443:130369.","DOI":"10.1016\/j.jhazmat.2022.130369"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77. Su Z, Wang K, Yang F, Zhuang T. Antibiotic pollution of the Yellow River in China and its relationship with dissolved organic matter: Distribution and Source identification. Water Res. 2023;235:119867.","DOI":"10.1016\/j.watres.2023.119867"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78. Lu S, Wang J, Wang B, Xin M, Lin C, Gu X, Lian M, Li Y. Comprehensive profiling of the distribution, risks and priority of pharmaceuticals and personal care products: A large-scale study from rivers to coastal seas. Water Res. 2023;230:119591.","DOI":"10.1016\/j.watres.2023.119591"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79. Zhang F, Mao X, Song X, Yu H, Yan J, Kong D, Liu Y, Yao N, Yang S, Xie S, Ji H, Zhou H. Ecological Risks of Antibiotics in Urban Wetlands on the Qinghai-Tibet Plateau, China. Int J Environ Res Public Health. 2023;20(3):1735.","DOI":"10.3390\/ijerph20031735"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80. Zhang Y, Liu L, Liu Y, Chen L, Wang J, Li Y, Wang K, Wang W. Deciphering the natural and anthropogenic drivers on the fate and risk of antibiotics and antibiotic resistance genes (ARGs) in a typical river-estuary system, China. J Hazard Mater. 2024;480:136006.","DOI":"10.1016\/j.jhazmat.2024.136006"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81. Hanna N, Tamhankar AJ, Lundborg CS. The development of an integrated environment-human risk approach for the prioritisation of antibiotics for policy decisions. Sci Total Environ. 2023;880:163301.","DOI":"10.1016\/j.scitotenv.2023.163301"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82. Oaks JL, Gilbert M, Virani MZ, Watson RT, Meteyer CU, Rideout BA, Shivaprasad HL, Ahmed S, Chaudhry MJ, Arshad M, Mahmood S, Ali A, Khan AA. Diclofenac residues as the cause of vulture population decline in Pakistan. Nature. 2004;427(6975):630\u20133.","DOI":"10.1038\/nature02317"},{"key":"83","unstructured":"83. European Commission. Review of Priority Substances under the WFD. Available online: http:\/\/ec.europa.eu\/environment\/water\/water-dangersub\/pri_substances.htm (accessed on 11 April 2025)."},{"key":"84","doi-asserted-by":"crossref","unstructured":"84. Duarte C, Di Lorenzo T, Reboleira ASPS. Environmental risk of diclofenac in European groundwaters and implications for environmental quality standards. Sci Rep. 2024;14(1):20689.","DOI":"10.1038\/s41598-024-71747-y"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85. Prakash V, Bishwakarma MC, Chaudhary A, Cuthbert R, Dave R, Kulkarni M, Kumar S, Paudel K, Ranade S, Shringarpure R, Green RE. The population decline of Gyps vultures in India and Nepal has slowed since veterinary use of diclofenac was banned. PLoS One. 2012;7(11):e49118.","DOI":"10.1371\/journal.pone.0049118"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86. Cuthbert R, Taggart MA, Prakash V, Saini M, Swarup D, Upreti S, Mateo R, Chakraborty SS, Deori P, Green RE. Effectiveness of action in India to reduce exposure of Gyps vultures to the toxic veterinary drug diclofenac. PLoS One. 2011;6(5):e19069.","DOI":"10.1371\/journal.pone.0019069"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87. Salvo F, Micallef J, Lahouegue A, Chouchana L, L\u00e9tinier L, Faillie JL, Pariente A. Will the future of pharmacovigilance be more automated? Expert Opin Drug Saf. 2023;22(7):541\u20138.","DOI":"10.1080\/14740338.2023.2227091"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88. Iqbal Z, Sadaf S. Biosimilars: A Comparative Study of Regulatory, Safety and Pharmacovigilance Monograph in the Developed and Developing Economies. J Pharm Pharm Sci. 2022;25:149\u201382.","DOI":"10.18433\/jpps32433"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89. Singh P, Vaishnav Y, Verma S. Development of Pharmacovigilance System in India and Paradigm of Pharmacovigilance Research: An Overview. Curr Drug Saf. 2023;18(4):448\u201364.","DOI":"10.2174\/1574886317666220930145603"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90. Le Lou\u00ebt H, Pitts PJ. Twenty-First Century Global ADR Management: A Need for Clarification, Redesign, and Coordinated Action. Ther Innov Regul Sci. 2023;57(1):100\u20133.","DOI":"10.1007\/s43441-022-00443-8"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91. Silva L, Pacheco T, Ara\u00fajo E, Duarte RJ, Ribeiro-Vaz I, Ferreira-da-Silva R. Unveiling the future: precision pharmacovigilance in the era of personalized medicine. Int J Clin Pharm. 2024;46(3):755\u201360.","DOI":"10.1007\/s11096-024-01709-x"},{"key":"92","doi-asserted-by":"crossref","unstructured":"92. Phougat P, Beniwal M, Kapoor G, Aggarwal N, Kumari A, Sharma R, Chopra H, Sharma R, Kamal MA. Role and Responsibilities of Various Stakeholders in Pharmacovigilance. Curr Drug Saf. 2025;20(1):19\u201332.","DOI":"10.2174\/0115748863277574240125045459"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93. Kjoersvik O, Bate A. Black Swan Events and Intelligent Automation for Routine Safety Surveillance. Drug Saf. 2022;45(5):419\u201327.","DOI":"10.1007\/s40264-022-01169-0"},{"key":"94","doi-asserted-by":"crossref","unstructured":"94. Filippi-Arriaga F, Aguilera C, Guill\u00e9n E, Bellas L, P\u00e9rez E, Vendrell L, Agust\u00ed A, Cereza G. Unknown adverse drug reactions from spontaneous reports in a hospital setting: characterization, follow-up, and contribution to the pharmacovigilance system. Front Pharmacol. 2023;14:1211786.","DOI":"10.3389\/fphar.2023.1211786"},{"key":"95","doi-asserted-by":"crossref","unstructured":"95. Lin S, Lei S, Liu W, Zhu X, Yin L, Liu Q, Feng B. Global trends in pharmacovigilance-related events: a 30-year analysis from the 2019 global burden of disease study. Int J Clin Pharm. 2024;46(5):1076\u201390.","DOI":"10.1007\/s11096-024-01738-6"},{"key":"96","doi-asserted-by":"crossref","unstructured":"96. Holm JEJ, Ruppert JG, Ramsden SD. Impact of Changing Regulations and the Dynamic Nature of European Risk Management Plans for Human Medicines on the Lifecycle of Safety Concerns. Pharmaceut Med. 2022;36(1):33\u201346.","DOI":"10.1007\/s40290-021-00414-8"},{"key":"97","doi-asserted-by":"crossref","unstructured":"97. Trifir\u00f2 G, Crisafulli S. A New Era of Pharmacovigilance: Future Challenges and Opportunities. Front Drug Saf Regul. 2022;2:866898.","DOI":"10.3389\/fdsfr.2022.866898"},{"key":"98","doi-asserted-by":"crossref","unstructured":"98. Bose D, Gogtay N, Goel T, Konwar M. An Audit of Black Box Warnings (BBWs) in the United States Food and Drug Administration (US-FDA) Database - A Five-Year Analysis. Curr Drug Saf. 2022;17(1):54\u20138.","DOI":"10.2174\/1574886316666210811161939"},{"key":"99","doi-asserted-by":"crossref","unstructured":"99. Dylan Fernandes S, Anoop NV, Castelino LJ, Narayana Charyulu R. A national approach to pharmacovigilance: The case of India as a growing hub of global clinical trials. Res Social Adm Pharm. 2019;15(1):109\u201313.","DOI":"10.1016\/j.sapharm.2018.03.061"},{"key":"100","doi-asserted-by":"crossref","unstructured":"100. Hauben M. Signal detection in the pharmaceutical industry: integrating clinical and computational approaches. Drug Saf. 2007;30(7):627\u201330.","DOI":"10.2165\/00002018-200730070-00012"},{"key":"101","doi-asserted-by":"crossref","unstructured":"101. Aparo A, Sala P, Bonnici V, Giugno R. TEDAR: Temporal dynamic signal detection of adverse reactions. Artif Intell Med. 2021;122:102212.","DOI":"10.1016\/j.artmed.2021.102212"},{"key":"102","doi-asserted-by":"crossref","unstructured":"102. Yan D, Bao S, Zhang Z, Sun J, Zhou M. Leveraging pharmacovigilance data to predict population-scale toxicity profiles of checkpoint inhibitor immunotherapy. Nat Comput Sci. 2025;5(3):207\u201320.","DOI":"10.1038\/s43588-024-00748-8"},{"key":"103","doi-asserted-by":"crossref","unstructured":"103. Yusoff FM, Abdullah AF, Aris AZ, Umi WA. Impacts of COVID-19 on the aquatic environment and implications on aquatic food production. Sustainability. 2021;13(20):11281.","DOI":"10.3390\/su132011281"},{"key":"104","doi-asserted-by":"crossref","unstructured":"104. Mallik A, Chakraborty P, Bhushan S, Nayak BB. Impact of COVID-19 lockdown on aquatic environment and fishing community: Boon or bane? Mar Policy. 2022;141:105088.","DOI":"10.1016\/j.marpol.2022.105088"},{"key":"105","doi-asserted-by":"crossref","unstructured":"105. Li S, Wen J, He B, Wang J, Hu X, Liu J. Occurrence of caffeine in the freshwater environment: Implications for ecopharmacovigilance. Environ Pollut. 2020;263(Pt B):114371.","DOI":"10.1016\/j.envpol.2020.114371"},{"key":"106","doi-asserted-by":"crossref","unstructured":"106. Wang J, Gao J, Liao M, Liu J, Hu X, He B. Attitudes and opinions about ecopharmacovigilance from multi-disciplinary perspectives: a cross-sectional survey among academic researchers in China. Environ Sci Pollut Res Int. 2023;30(1):2273\u201382.","DOI":"10.1007\/s11356-022-22406-0"},{"key":"107","doi-asserted-by":"crossref","unstructured":"107. Li Q, Wei S, Zhu Z, Wang J. Adopting eco-pharmacovigilance practices to reduce risks posed by disinfectants in the environment: possibility and challenges. Sustain Chem Pharm. 2025;46:102081.","DOI":"10.1016\/j.scp.2025.102081"}],"container-title":["Environmental Health and Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ehpm\/31\/0\/31_25-00395\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:18:10Z","timestamp":1783142290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ehpm\/31\/0\/31_25-00395\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":107,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1265\/ehpm.25-00395","relation":{},"ISSN":["1342-078X","1347-4715"],"issn-type":[{"value":"1342-078X","type":"print"},{"value":"1347-4715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"25-00395"}}